Prothena Corp PLC (PRTA)
10.99
+0.75 +7.32%
NASDAQ
Nov 19, 12:26
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 0.752M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.97 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -78.58M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -9.49K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0% |
| Price and Valuation | |
| Market Cap | 438.46M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 582.74 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 1.516 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.00 |
| Free Cash Flow (Quarterly) | -9.192M |
| Return on Equity (TTM) | Upgrade |
View All PRTA News
News
-
WireHeadlineTime (ET)
-
SA Breaking News11/19 11:16
-
Yahoo11/19 11:03
-
SA Breaking News11/19 08:12
-
MT Newswires11/19 08:02
-
Yahoo11/06 15:14
-
Yahoo11/05 18:55
-
Globe Newswire11/05 16:05
-
Globe Newswire10/29 16:05
-
Yahoo10/29 10:32
-
Yahoo10/15 01:49
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 02/14/2020 16:30 EST | Misc | Prothena Corp PLC Fourth Quarter Earnings Conference Call in 2019 |
| 02/14/2020 | Earnings | Prothena Corp PLC Fourth Quarter Earnings in 2019 Release |
| 11/05/2019 | Earnings | Prothena Corp PLC Third Quarter Earnings Results for 2019 |
| 08/06/2019 | Earnings | Prothena Corp PLC Second Quarter Earnings Results in 2019 |
| 05/21/2019 16:00 IST | Misc | Prothena Corp PLC Annual General Meeting in 2018 |
| 05/07/2019 | Earnings | Prothena Corp PLC First Quarter Earnings Results in 2019 |
| 03/15/2019 | Misc | Prothena Corp PLC Annual Report in 2018 |
| 02/14/2019 16:30 EST | Misc | Prothena Corp PLC Fourth Quarter Earnings Conference Call in 2018 |
| 02/14/2019 | Earnings | Prothena Corp PLC Fourth Quarter Earnings in 2018 Release |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.prothena.com
- Investor Relations URL: http://ir.prothena.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Blend
- Next Earnings Release: Feb. 14, 2020
- Last Earnings Release: Nov. 05, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Prothena Corp PLC is a biotechnology company focuses on the discovery, development, and commercialization of novel protein immunotherapies for the treatment of diseases that involve protein misfolding and inflammatory cell adhesion disorders. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 10.99 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| PQSV | PGIM QMA Strategic Alpha Sm-Cp Val ETF | 0.17% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- PRTA Tweets Stocktwits
Advertisement
